By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Xenon Pharmaceuticals Inc. (Formerly Xenon Genetics) 

3650 Gilmore Way

Burnaby  British Columbia  V5G 4W8  Canada
Phone: 604-484-3300 Fax: 604-484-3450


SEARCH JOBS


Industry
Biotechnology

Segment
Genomics





Company News
Teva (TEVA) And Xenon Pharmaceuticals Inc. Announce Enrollment Of First Patient In A Phase 2b Study Evaluating TV-45070 For Postherpetic Neuralgia (PHN) 4/2/2015 7:08:09 AM
Xenon Pharmaceuticals Inc. Appoints Dr. Richard H. Scheller To Its Board Of Directors 3/16/2015 8:02:07 AM
Xenon Pharmaceuticals Inc. Reports 2014 Financial Results And Provides Corporate Update 3/13/2015 7:20:43 AM
Xenon Pharmaceuticals Inc. Partner Teva Pharmaceutical Industries (TEVA) To Initiate Phase 2b Clinical Trial Of TV-45070 In Post-Herpetic Neuralgia 2/20/2015 7:13:19 AM
Xenon Pharmaceuticals Inc. Outlines Key Anticipated Milestones For 2015 1/8/2015 8:03:43 AM
Xenon Pharmaceuticals Inc. Reports Third Quarter 2014 Financial Results 12/15/2014 8:15:15 AM
Xenon Pharmaceuticals Inc. Announces Closing Of Initial Public Offering And Full Exercise Of The Underwriters' Option To Purchase Additional Shares 11/11/2014 7:32:14 AM
Xenon Pharmaceuticals Inc. Announces Pricing Of Initial Public Offering 11/5/2014 7:20:18 AM
Xenon Pharmaceuticals Inc. Postpones IPO 10/20/2014 6:47:32 AM
Rare Disease Biotech Xenon Pharmaceuticals Inc. Files For $52 Million IPO 9/10/2014 9:01:53 AM
1234
//-->